Introduction: Obesity is usually considered a risk factor for postoperative complications; however, previous studies conclude contradictory results in retroperitoneal laparoscopic adrenalectomy (LA). We aim to evaluate the impact of obesity on the perioperative outcomes of LA. Methods: A retrospective cohort study from a single center including 353 patients from 2011 to 2013 was conducted. Perioperative outcomes of patients from different groups were compared according to their body mass index (BMI). Results: All the patients were divided into 3 groups: normal (n = 149), overweight (n = 141) and obese (n = 63). Operative time (OT) for patients belonging to the obese group was significantly longer than that in the normal and overweight group, and the results of estimated blood loss, postoperative length of stay in hospital and postoperative complications were all similar. In the multivariate logistic regression analysis, OT was an independent risk factor for postoperative complications (odds ratio 1.020; 95% confidence interval 1.001-1.039; p = 0.037), while other factors including BMI had negligible effect. Conclusions: Retroperitoneal LA offers similar perioperative outcomes for patients with different obesity statuses, which could be safe and feasible for obese patients.

Keywords:
Adrenalectomy, Body mass index, Laparoscopic surgery, Obesity, Complication
1.
Gagner M, Lacroix A, Bolté E: Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 1992;327:1033.
2.
Stefanidis D, Goldfarb M, Kercher KW, Hope WW, Richardson W, Fanelli RD; Society of Gastrointestinal and Endoscopic Surgeons: SAGES guidelines for minimally invasive treatment of adrenal pathology. Surg Endosc 2013;27:3960-3980.
3.
Mercan S, Seven R, Ozarmagan S, Tezelman S: Endoscopic retroperitoneal adrenalectomy. Surgery 1995;118:1071-1075.
4.
Taskin HE, Siperstein A, Mercan S, Berber E: Laparoscopic posterior retroperitoneal adrenalectomy. J Surg Oncol 2012;106:619-621.
5.
Constantinides VA, Christakis I, Touska P, Palazzo FF: Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 2012;99:1639-1648.
6.
Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, Ramacciato G, Melis M: Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery 2013;153:111-119.
7.
Hyde R: Europe battles with obesity. Lancet 2008;371:2160-2161.
8.
Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
9.
Chen C, Lu FC; Department of Disease Control Ministry of Health, PR China: The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 2004;17(suppl):1-36.
10.
Dindo D, Muller MK, Weber M, Clavien PA: Obesity in general elective surgery. Lancet 2003;361:2032-2035.
11.
Aboumarzouk OM, Stein RJ, Haber GP, Kaouk J, Chlosta PL, Somani BK: Laparoscopic partial nephrectomy in obese patients: a systematic review and meta-analysis. BJU Int 2012;110:1244-1250.
12.
Gonzalez R, Smith CD, McClusky DA 3rd, Ramaswamy A, Branum GD, Hunter JG, Weber CJ: Laparoscopic approach reduces likelihood of perioperative complications in patients undergoing adrenalectomy. Am Surg 2004;70:668-674.
13.
Park HS, Roman SA, Sosa JA: Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Arch Surg 2009;144:1060-1067.
14.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M: The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196.
15.
World Health Organization: Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva, Switzerland, 2000.
16.
Miccoli P, Materazzi G, Brauckhoff M, Ambrosini CE, Miccoli M, Dralle H: No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. World J Surg 2011;35:2698-2702.
17.
Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND: Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery 2011;150:452-458.
18.
Kazaure HS, Roman SA, Sosa JA: Obesity is a predictor of morbidity in 1,629 patients who underwent adrenalectomy. World J Surg 2011;35:1287-1295.
19.
Kazaryan AM, Marangos IP, Røsok BI, Rosseland AR, Edwin B: Impact of body mass index on outcomes of laparoscopic adrenal surgery. Surg Innov 2011;18:358-367.
20.
Epelboym I, Digesu CS, Johnston MG, Chabot JA, Inabnet WB, Allendorf JD, Lee JA: Expanding the indications for laparoscopic retroperitoneal adrenalectomy: experience with 81 resections. J Surg Res 2014;187:496-501.
21.
Chiang PH, Yu CJ, Lee WC, Wang HJ, Hsu WC: Comparison of retroperitoneoscopic and transperitoneal laparoscopic adrenalectomy for right-sided benign tumors: a single-institute experience. Urol Int 2015;94:144-148.
22.
Arslan M, Akin Y, Ates M, Degirmenci T, Kozacioglu Z, Ors B, Gunlusoy B: Changing surgical approaches for laparoscopic adrenalectomy: single-surgeon data of a 6-year experience. Urol Int 2013;91:304-309.
23.
Shi TP, Zhang X, Ma X, Li HZ, Zhu J, Wang BJ, Gao JP, Cai W, Dong J: Laparoendoscopic single-site retroperitoneoscopic adrenalectomy: a matched-pair comparison with the gold standard. Surg Endosc 2011;25:2117-2124.
24.
Pelosi P, Gregoretti C: Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol 2010;24:211-225.
25.
Doyle SL, Lysaght J, Reynolds JV: Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 2010;11:875-886.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.